Combined the SMAC mimetic and BCL2 inhibitor sensitizes neoadjuvant chemotherapy by targeting necrosome complexes in tyrosine aminoacyl-tRNA synthase-positive breast cancer
- Kyung Min Lee
- , Hyebin Lee
- , Dohyun Han
- , Woo Kyung Moon
- , Kwangsoo Kim
- , Hyeon Jeong Oh
- , Jinwoo Choi
- , Eun Hye Hwang
- , Seong Eun Kang
- , Seock Ah Im
- , Kyung Hun Lee
- , Han Suk Ryu
- Seoul National University
- Kangbuk Samsung Hospital
- National Cancer Center
Research output: Contribution to journal › Article › peer-review
23
Link opens in a new tab
Scopus
citations